Swiss Rockets AG has acquired Complete Genomics, a pioneering life sciences company headquartered in San Jose, California, for an undisclosed amount. This corporate acquisition signifies a strategic expansion for Swiss Rockets AG within the rapidly evolving biotechnology sector, integrating advanced genomic capabilities into its operational framework.
Complete Genomics, established in 2005, has consistently led the way in the development of high-throughput sequencing technology. Its mission is to drive genomics forward with complete sequencing solutions that improve lives. The company's comprehensive product lineup encompasses critical stages of genomic analysis, including sample extraction, library preparation, lab automation, DNBSEQ sequencing, and sophisticated data analysis tools. These offerings have positioned Complete Genomics as a key innovator in the field.
The acquisition is a strategic move for Swiss Rockets AG, a company focused on fostering innovation and growth within the life sciences. By bringing Complete Genomics under its ownership, Swiss Rockets AG gains immediate access to a robust portfolio of cutting-edge genomic technologies and an experienced team. This integration is expected to generate significant synergies, combining Swiss Rockets AG's strategic resources and market insights with Complete Genomics' deep scientific expertise and established technological platforms.
This strategic alignment aims to accelerate the development and broader application of advanced sequencing solutions. The combined entity is now positioned to enhance its impact across various life science domains, from research to clinical applications. By leveraging Complete Genomics' proven infrastructure and innovative technology, Swiss Rockets AG intends to further drive advancements in genomics, delivering more comprehensive and accessible solutions that contribute to improving lives globally.